Metabolic reprogramming in cholangiocarcinoma

C Raggi, ML Taddei, C Rae, C Braconi, F Marra - Journal of hepatology, 2022 - Elsevier
Metabolic reprogramming is a hallmark of cancer and allows tumour cells to meet the
increased energy demands required for rapid proliferation, invasion, and metastasis …

[HTML][HTML] Sustained proliferation in cancer: Mechanisms and novel therapeutic targets

MA Feitelson, A Arzumanyan, RJ Kulathinal… - Seminars in cancer …, 2015 - Elsevier
Proliferation is an important part of cancer development and progression. This is manifest by
altered expression and/or activity of cell cycle related proteins. Constitutive activation of …

NAFLD, NASH and liver cancer

GA Michelotti, MV Machado, AM Diehl - … reviews Gastroenterology & …, 2013 - nature.com
NAFLD affects a large proportion of the US population and its incidence and prevalence are
increasing to epidemic proportions around the world. As with other liver diseases that cause …

S-adenosylmethionine in Liver Health, Injury, and Cancer

SC Lu, JM Mato - Physiological reviews, 2012 - journals.physiology.org
S-adenosylmethionine (AdoMet, also known as SAM and SAMe) is the principal biological
methyl donor synthesized in all mammalian cells but most abundantly in the liver …

[HTML][HTML] Loss of liver function in chronic liver disease: An identity crisis

C Berasain, M Arechederra, J Argemí… - Journal of …, 2023 - Elsevier
Adult hepatocyte identity is constructed throughout embryonic development and fine-tuned
after birth. A multinodular network of transcription factors, along with pre-mRNA splicing …

Role of oxidative stress in alcohol-induced liver injury

AI Cederbaum, Y Lu, D Wu - Archives of toxicology, 2009 - Springer
Reactive oxygen species (ROS) are highly reactive molecules that are naturally generated
in small amounts during the body's metabolic reactions and can react with and damage …

Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis

L Amitrano, MA Guardascione, V Brancaccio… - Journal of …, 2004 - Elsevier
BACKGROUND/AIMS: Portal vein thrombosis in patients with liver cirrhosis is usually
associated to hepatocellular carcinoma. Clinical presentation of non-neoplastic portal vein …

Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis

J Argemi, MU Latasa, SR Atkinson, IO Blokhin… - Nature …, 2019 - nature.com
Alcoholic hepatitis (AH) is a life-threatening condition characterized by profound
hepatocellular dysfunction for which targeted treatments are urgently needed. Identification …

[HTML][HTML] S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility

QM Anstee, CP Day - Journal of hepatology, 2012 - Elsevier
S-adenosyl-l-methionine (SAMe; AdoMet) is an important, metabolically pleiotropic molecule
that participates in multiple cellular reactions as the precursor for the synthesis of glutathione …

[HTML][HTML] Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg

MG Fernández-Barrena, M Arechederra, L Colyn… - Jhep Reports, 2020 - Elsevier
Hepatocellular carcinoma (HCC) is a deadly tumour whose causative agents are generally
well known, but whose pathogenesis remains poorly understood. Nevertheless, key genetic …